HGS Execs Hid Lupus Drug's Suicide Link: Suit

By Ian Thoms · December 22, 2011, 6:12 PM EST

A Human Genome Sciences Inc. shareholder lodged a derivative complaint Wednesday against the biotech company's CEO and several other officers and directors, alleging they hid from investors the fact that lupus...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Forgione v. Watkins et al

Case Number

Court

Maryland

Nature of Suit

Stockholders Suits

Date Filed

December 20, 2011

Recent Articles By Ian

September 07, 2012
WellPoint Price-Fixing MDL Survives Dismissal Bids
September 06, 2012
Universal Health Relators Win $1.4M Piece Of FCA Deal
August 03, 2012
Ex-Ala. Gov. Returning To Prison For 6 1/2 Years
February 15, 2012
Illumina Investors Claim Goldman Bias In Suit Over Roche Bid
January 25, 2012
UK Probes Simplyhealth's $180M Dental Insurance Co. Buy
January 17, 2012
Olympus Panel Clears KPMG, Ernst & Young In Fraud Probe
December 21, 2011
Immersion Beats $300M Suit Over Pumped-Up Stock Prices
December 21, 2011
Olympus Tokyo Offices Raided In Probe Of $2B Fraud
December 14, 2011
Olympus Recognizes $1B Loss To Avoid Stock Delisting
December 06, 2011
Olympus Panel Urges Legal Measures Against 'Rotten' Execs